Amgen 28 avr. 2026 FDA turns up heat on Amgen, proposing to rescind approval of Tavneos - Fierce Pharma
Amgen 24 avr. 2026 Amgen’s Chief Technology Officer Dr David Reese to retire - European Pharmaceutical Review
Amgen 20 avr. 2026 Zurcher Kantonalbank Zurich Cantonalbank Buys 55,333 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen 20 avr. 2026 Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP (PFE:NYSE) - Seeking Alpha
Amgen 16 avr. 2026 Federal Circuit Distinguishes Amgen in Reversal of Invalidation of Teva Headache Treatment Patents - IPWatchdog.com
Amgen 15 sept. 2025 Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences - California State Portal | CA.gov